본문 바로가기
KERD
논문KCI 등재

Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites

이은숙|손덕수|Rosa Mistica C. Ignacio|Andrew J. Wilson|Alicia Beeghly-Fadiel|Margaret M. Whalen
대한면역학회 (The Korean Association of Immunologists)|2018.12|Immune Network|제18권 제6호|pp. 1-14|DOI https://doi.org/10.4110/in.2018.18.e47

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

ObesityOvarian cancerAscitesChemokinesMacrophages

초록

One-fifth of cancer deaths are associated with obesity. Because the molecular mechanisms by which obesity affects the progression of ovarian cancer (OC) are poorly understood, we investigated if obesity could promote the progression of OC cells using the postmenopausal ob/ob mouse model and peritoneal dissemination of mouse ID8 OC cells. Compared to lean mice, obese mice had earlier OC occurrence, greater metastasis throughout the peritoneal cavity, a trend toward shorter survival, and higher circulating glucose and proinflammatory chemokine CXCL1 levels. Ascites in obese mice had higher levels of macrophages (Mφ) and chemokines including CCL2, CXCL12, CXCL13, G-CSF and M-CSF. Omental tumor tissues in obese mice had more adipocytes than lean mice. Our data suggest that obesity may accelerate the peritoneal dissemination of OC through higher production of pro-inflammatory chemokines and Mφ recruitment.

Abstract

One-fifth of cancer deaths are associated with obesity. Because the molecular mechanisms by which obesity affects the progression of ovarian cancer (OC) are poorly understood, we investigated if obesity could promote the progression of OC cells using the postmenopausal ob/ob mouse model and peritoneal dissemination of mouse ID8 OC cells. Compared to lean mice, obese mice had earlier OC occurrence, greater metastasis throughout the peritoneal cavity, a trend toward shorter survival, and higher circulating glucose and proinflammatory chemokine CXCL1 levels. Ascites in obese mice had higher levels of macrophages (Mφ) and chemokines including CCL2, CXCL12, CXCL13, G-CSF and M-CSF. Omental tumor tissues in obese mice had more adipocytes than lean mice. Our data suggest that obesity may accelerate the peritoneal dissemination of OC through higher production of pro-inflammatory chemokines and Mφ recruitment.

참고문헌 (81)

  1. Arroyo-Johnson C, "Obesity epidemiology worldwide", Gastroenterol Clin North Am, 45, pp.571~579 (2016)
  2. Calle EE, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults", N Engl J Med, 348, pp.1625~1638 (2003)
  3. Smith KB, "Obesity statistics", Prim Care, 43, pp.121~135 (2016)
  4. Torre LA, "Ovarian cancer statistics, 2018", CA Cancer J Clin, 68, pp.284~296 (2018)
  5. Yeung TL, "Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis", Am J Physiol Cell Physiol, 309, pp.C444~C456 (2015)
  6. Pavelka JC, "Effect of obesity on survival in epithelial ovarian cancer", Cancer, 107, pp.1520~1524 (2006)
  7. Diaz ES, "Obesity-associated adipokines correlate with survival in epithelial ovarian cancer", Gynecol Oncol, 129, pp.353~357 (2013)
  8. Protani MM, "Obesity and ovarian cancer survival: a systematic review and meta-analysis", Cancer Prev Res (Phila), 5, pp.901~910 (2012)
  9. Farrow DC, "Association of obesity and ovarian cancer in a case-control study", Am J Epidemiol, 129, pp.1300~1304 (1989)
  10. Matthews KS, "The effect of obesity on survival in patients with ovarian cancer", Gynecol Oncol, 112, pp.389~393 (2009)
  11. Skírnisdóttir I, "Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer", Int J Gynecol Cancer, 18, pp.345~351 (2008)
  12. Fairfield KM, "Obesity, weight gain, and ovarian cancer", Obstet Gynecol, 100, pp.288~296 (2002)
  13. Poorolajal J, "Body mass index effects on risk of ovarian cancer: a meta- analysis", Asian Pac J Cancer Prev, 15, pp.7665~7671 (2014)
  14. Schildkraut JM, "A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES)", BMC Cancer, 14, pp.688~ (2014)
  15. Wu MM, "A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels", PLoS One, 9, pp.e104630~ (2014)
  16. Smits A, "Quality of life in ovarian cancer survivors: the influence of obesity", Int J Gynecol Cancer, 25, pp.616~621 (2015)
  17. Kumar A, "Impact of obesity on surgical and oncologic outcomes in ovarian cancer", Gynecol Oncol, 135, pp.19~24 (2014)
  18. Doll KM, "Obesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes", Cancer, 121, pp.395~402 (2015)
  19. Olsen CM, "Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis", Eur J Cancer, 43, pp.690~709 (2007)
  20. Yang HS, "Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies", Int J Gynecol Cancer, 21, pp.1525~1532 (2011)
  21. Hursting SD, "Obesity, energy balance, and cancer: new opportunities for prevention", Cancer Prev Res (Phila), 5, pp.1260~1272 (2012)
  22. Sundaram S, "Obesity, metabolism and the microenvironment: Links to cancer", J Carcinog, 12, pp.19~ (2013)
  23. Rondinone CM., "Adipocyte-derived hormones, cytokines, and mediators", Endocrine, 29, pp.81~90 (2006)
  24. Balkwill FR., "The chemokine system and cancer", J Pathol, 226, pp.148~157 (2012)
  25. Mantovani A, "The chemokine system in cancer biology and therapy", Cytokine Growth Factor Rev, 21, pp.27~39 (2010)
  26. Son DS, "Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB", PLoS One, 7, pp.e51116~ (2012)
  27. Son DS, "Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells", J Inflamm (Lond), 10, pp.25~ (2013)
  28. Son DS, "Keratinocyte chemoattractant (KC)", human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells, 2007, pp.6, 1302~1312
  29. Son DS, "Interleukin-1alpha-induced chemokines in mouse granulosa cells: impact on keratinocyte chemoattractant chemokine, a CXC subfamily", Mol Endocrinol, 20, pp.2999~3013 (2006)
  30. Kabir SM, "Chemokine network during adipogenesis in 3T3-L1 cells: Differential response between growth and proinflammatory factor in preadipocytes vs. adipocytes", Adipocyte, 3, pp.97~106 (2014)
  31. Ignacio RM, "CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer", Oncotarget, 9, pp.9751~9765 (2018)
  32. Cancer Genome Atlas Research Network., "Integrated genomic analyses of ovarian carcinoma", Nature, 474, pp.609~615 (2011)
  33. Dong YL, "CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling", PLoS One, 8, pp.e83789~ (2013)
  34. Rosa Mistica C. Ignacio, "Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer", Immune Network, 18(4), pp.1~13 (2018), 대한면역학회[DOI]
  35. Ignacio RM, "NF-κB-mediated CCL20 reigns dominantly in CXCR2-driven ovarian cancer progression", PLoS One, 11, pp.e0164189~ (2016)
  36. Harper EI, "With great age comes great metastatic ability: ovarian cancer and the appeal of the aging peritoneal microenvironment", Cancers (Basel), 10, pp.E230~ (2018)
  37. Arao Y, "N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure", Mol Metab, 18, pp.68~78 (2018)
  38. Hong J, "Differential susceptibility to obesity between male, female and ovariectomized female mice", Nutr J, 8, pp.11~ (2009)
  39. Liu Y, "Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages", Cancer Res, 75, pp.5046~5057 (2015)
  40. Ingalls AM, "Obese, a new mutation in the house mouse", J Hered, 41, pp.317~318 (1950)
  41. Han J, "Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice", Oncotarget, 8, pp.110965~110982 (2017)
  42. Makowski L, "Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer", Gynecol Oncol, 133, pp.90~97 (2014)
  43. Nunemaker CS, "Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function", J Endocrinol, 222, pp.267~276 (2014)
  44. Zhang T, "CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment", Nat Commun, 7, pp.11674~ (2016)
  45. Gupta V, "Bipolar tumor-associated macrophages in ovarian cancer as targets for therapy", Cancers (Basel), 10, pp.E366~ (2018)
  46. Yuan X, "Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis", Gynecol Oncol, 147, pp.181~187 (2017)
  47. Lan C, "Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer", Technol Cancer Res Treat, 12, pp.259~267 (2013)
  48. Ke X, "Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer", Int Immunopharmacol, 40, pp.184~195 (2016)
  49. Cho U, "Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation", Mol Carcinog, 57, pp.235~242 (2018)
  50. Moughon DL, "Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer", Cancer Res, 75, pp.4742~4752 (2015)
  51. Arendt LM, "Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis", Cancer Res, 73, pp.6080~6093 (2013)
  52. Kanda H, "MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity", J Clin Invest, 116, pp.1494~1505 (2006)
  53. Kim CS, "Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters", Int J Obes, 30, pp.1347~1355 (2006)
  54. Kim D, "CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice", Diabetologia, 57, pp.1456~1465 (2014)
  55. Peng H, "Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity", Biochem Biophys Res Commun, 479, pp.649~655 (2016)
  56. Saha A, "Proinflammatory CXCL12-CXCR4", CXCR7 signaling axis drives Myc-induced prostate cancer in obese mice, 2017, pp.77, 5158~5168
  57. Yu L, "Transcriptional and translational-uncoupling in regulation of the CXCL12 and its receptors CXCR4, 7 in THP-1 monocytes and macrophages", Immun Inflamm Dis, 6, pp.106~116 (2018)
  58. Park JY, "Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer", Clin Res Hepatol Gastroenterol, 40, pp.357~365 (2016)
  59. Kusuyama J, "CXCL3 positively regulates adipogenic differentiation", J Lipid Res, 57, pp.1806~1820 (2016)
  60. Carlsen HS, "Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis", Blood, 104, pp.3021~3027 (2004)
  61. Kaye S, "Upregulation of early and downregulation of terminal pathway complement genes in subcutaneous adipose tissue and adipocytes in acquired obesity", Front Immunol, 8, pp.545~ (2017)
  62. Tvarijonaviciute A, "Obese dogs with and without obesity-related metabolic dysfunction - a proteomic approach", BMC Vet Res, 12, pp.211~ (2016)
  63. Rigo A, "Macrophages may promote cancer growth via a GM-CSF", HB-EGF paracrine loop that is enhanced by CXCL12, 2010, pp.9, 273~
  64. Lee Y, "Anti-obesity effects of granulocyte-colony stimulating factor in Otsuka-Long-Evans-Tokushima fatty rats", PLoS One, 9, pp.e105603~ (2014)
  65. Hibbs ML, "Mice lacking three myeloid colony-stimulating factors (G-CSF, GM-CSF, and M-CSF) still produce macrophages and granulocytes and mount an inflammatory response in a sterile model of peritonitis", J Immunol, 178, pp.6435~6443 (2007)
  66. Meshkibaf S, "G-CSF preferentially supports the generation of gut-homing Gr-1high macrophages in M-CSF-treated bone marrow cells", J Leukoc Biol, 96, pp.549~561 (2014)
  67. Jung JI, "High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages", Int J Cancer, 136, pp.258~270 (2015)
  68. Toy EP, "Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor", Neoplasia, 11, pp.136~144 (2009)
  69. Kim EJ, "Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB", c mice, 2011, pp.13, R78~
  70. Sugita S, "Macrophage-colony stimulating factor in obese adipose tissue: studies with heterozygous op", + mice, 2007, pp.15, 1988~1995
  71. Shimada-Hiratsuka M, "Defective macrophage recruitment and clearance of apoptotic cells in the uterus of osteopetrotic mutant mice lacking macrophage colony-stimulating factor (M-CSF)", J Submicrosc Cytol Pathol, 32, pp.297~307 (2000)
  72. Harman-Boehm I, "Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity", J Clin Endocrinol Metab, 92, pp.2240~2247 (2007)
  73. Lijnen HR, "Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice", Thromb Haemost, 89, pp.249~255 (2003)
  74. Maury E, "Adipokines oversecreted by omental adipose tissue in human obesity", Am J Physiol Endocrinol Metab, 293, pp.E656~E665 (2007)
  75. Maury E, "Effect of obesity on growth-related oncogene factor-alpha, thrombopoietin, and tissue inhibitor metalloproteinase-1 serum levels", Obesity (Silver Spring), 18, pp.1503~1509 (2010)
  76. Hardaway AL, "Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer", Clin Exp Metastasis, 32, pp.353~368 (2015)
  77. Tebbe C, "Metformin limits the adipocyte tumor-promoting effect on ovarian cancer", Oncotarget, 5, pp.4746~4764 (2014)
  78. Xiong Y, "Hematopoietic Stem Cell-derived Adipocytes Promote Tumor Growth and Cancer Cell Migration", International Journal of Cancer Research and Molecular Mechanisms, 3(1) (2017), Sci Forschen, Inc.[DOI]
  79. Moreira Â, "Adipocyte secreted factors enhance aggressiveness of prostate carcinoma cells", PLoS One, 10, pp.e0123217~ (2015)
  80. Fujisaki K, "Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1", Breast Cancer Res Treat, 150, pp.255~263 (2015)
  81. Ribeiro R, "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro", J Exp Clin Cancer Res, 31, pp.32~ (2012)

관련 논문AI추천

Potential Roles of Innate Immune Chemokine and Cytokine Network on Lipopolysaccharide-Based Therapeutic Approach in Ovarian Cancer손덕수, 이은숙, Rosa Mistica C. Ignacio대한면역학회 · Immune Network2019 · 제19권 제3호Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer주웅, 김승철, 김윤환, 김찬영, 김현정, 진징휘대한산부인과학회 · Obstetrics & Gynecology Science2016 · 제59권 제4호Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway데니, 김보연, 김수지, 김희승, 송용상, Benjamin K. Tsang, Guy Haegeman대한암학회 · Cancer Research and Treatment2017 · 제49권 제2호Polarization of M2 Macrophages by Interaction between Prostate Cancer Cells Treated with Trichomonas vaginalis and Adipocytes김정현, 류재숙, 정효영, 한익환대한기생충학ㆍ열대의학회 · Parasites, Hosts and Diseases2020 · 제58권 제3호Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal CancerChang Soo Yeon, Cheon Jae Hee, Kim Tae Il, Kim Won Ho, Lim Joon Seok, Park Jae Jun, Park Jung Won, Park Soo Jung거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제1호Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer손덕수, 이은숙, Alicia Beeghly-Fadiel, Andrew J. Wilson, Margaret M. Whalen, Rosa Mistica C. Ignacio대한면역학회 · Immune Network2018 · 제18권 제4호

이 간행물의 다른 논문 (6건)

Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD강명수, 최은영, 민창기, 신동미, 오세화, 이영관, 주지민, 손우정pp. 1-23Regulatory Roles of the Caspase-11 Non-Canonical Inflammasome in Inflammatory Diseases이영수pp. 1-15From Bench to Clinic: the Potential of Therapeutic Targeting of the IL-22 Signaling Pathway in Atopic Dermatitis윤주한, 진미림pp. 1-11Extracellular Vesicles of Neutrophils홍장원pp. 1-9Two-Round Mixed Lymphocyte Reaction for Evaluation of the Functional Activities of Anti-PD-1 and Immunomodulators신의철, 최영준, 박수형, 권민석, 사모아pp. 1-11
원문 보기